EMFAT
Emerald Mutual Fund Advisers Trust’s Acadia Pharmaceuticals ACAD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.89M | Sell |
319,306
-175,778
| -36% | -$3.79M | 0.42% | 88 |
|
|
2025
Q1 | $8.22M | Sell |
495,084
-5,307
| -1% | -$88.1K | 0.58% | 69 |
|
|
2024
Q4 | $9.18M | Sell |
500,391
-74,419
| -13% | -$1.37M | 0.56% | 70 |
|
|
2024
Q3 | $8.84M | Buy |
574,810
+15,961
| +3% | +$245K | 0.46% | 76 |
|
|
2024
Q2 | $9.08M | Sell |
558,849
-691,380
| -55% | -$11.2M | 0.48% | 78 |
|
|
2024
Q1 | $23.1M | Sell |
1,250,229
-54,327
| -4% | -$1M | 1.2% | 24 |
|
|
2023
Q4 | $40.8M | Buy |
1,304,556
+568
| +0% | +$17.8K | 2.16% | 1 |
|
|
2023
Q3 | $27.2M | Buy |
1,303,988
+12,894
| +1% | +$269K | 1.64% | 9 |
|
|
2023
Q2 | $30.9M | Buy |
1,291,094
+83,792
| +7% | +$2.01M | 1.68% | 4 |
|
|
2023
Q1 | $22.7M | Buy |
1,207,302
+158,552
| +15% | +$2.98M | 1.34% | 17 |
|
|
2022
Q4 | $16.7M | Buy |
1,048,750
+16,011
| +2% | +$255K | 1.03% | 39 |
|
|
2022
Q3 | $16.9M | Buy |
1,032,739
+265,768
| +35% | +$4.35M | 1.07% | 30 |
|
|
2022
Q2 | $10.8M | Buy |
766,971
+116,978
| +18% | +$1.65M | 0.63% | 64 |
|
|
2022
Q1 | $15.7M | Sell |
649,993
-57,976
| -8% | -$1.4M | 0.7% | 57 |
|
|
2021
Q4 | $16.5M | Buy |
+707,969
| New | +$16.5M | 0.58% | 66 |
|